Estimated out-of-pocket savings per inhaler (30-day supply) among fills experiencing some savings in the employer-sponsored insurance market, overall and by drug manufacturer
Note: Claims data from 2023 was used to estimate potential savings from voluntary out-of-pocket spending caps within the employer-sponsored insurance market. Estimates shown are only among fills for inhalers that are subject to a voluntary spending cap and are estimated to experience some (>$0) savings.
